Dr. Berger’s session will explore the development of MSK-IMPACT and MSK-ACCESS, MSK’s comprehensive genomic profiling and cfDNA analysis programs. These initiatives address the need for large-scale ...

The term ‘mainstreaming’ was first used in 2003 by the Secretary of State for Health in the context of the genetics white paper Our Inheritance, Our Future when he argued that genomics must move from ...

GSK and Genomics plc will collaborate on a new precision medicine initiative that assesses how genetic data can be used in clinical trial design, Genomics announced April 30. The project will look at ...

Newly formed partnership enables clinical genomics laboratories to move from sample to evidence-backed analysis to actionable clinical reports using a push-button solution WASHINGTON--(BUSINESS WIRE)- ...

ST. LOUIS--(BUSINESS WIRE)--Cofactor Genomics, Inc., a clinical-stage company bridging the precision medicine gap by decoding RNA, announced today the validation and launch of OncoPrism ®-NSCLC, an ...

Researchers from the Perelman School of Medicine at the University of Pennsylvania have received two highly competitive post-doctoral Institutional Training Grants for genomic science from the ...